Matches in SemOpenAlex for { <https://semopenalex.org/work/W1967599448> ?p ?o ?g. }
- W1967599448 endingPage "1182" @default.
- W1967599448 startingPage "1178" @default.
- W1967599448 abstract "The RITUXVAS trial reported similar remission induction rates and safety between rituximab and cyclophosphamide based regimens for antineutrophil cytoplasm antibody (ANCA)-associated vasculitis at 12 months; however, immunosuppression maintenance requirements and longer-term outcomes after rituximab in ANCA-associated renal vasculitis are unknown.Forty-four patients with newly diagnosed ANCA-associated vasculitis and renal involvement were randomised, 3:1, to glucocorticoids plus either rituximab (375 mg/m(2)/week×4) with two intravenous cyclophosphamide pulses (n=33, rituximab group), or intravenous cyclophosphamide for 3-6 months followed by azathioprine (n=11, control group).The primary end point at 24 months was a composite of death, end-stage renal disease and relapse, which occurred in 14/33 in the rituximab group (42%) and 4/11 in the control group (36%) (p=1.00). After remission induction treatment all patients in the rituximab group achieved complete B cell depletion and during subsequent follow-up, 23/33 (70%) had B cell return. Relapses occurred in seven in the rituximab group (21%) and two in the control group (18%) (p=1.00). All relapses in the rituximab group occurred after B cell return.At 24 months, rates of the composite outcome of death, end-stage renal disease and relapse did not differ between groups. In the rituximab group, B cell return was associated with relapse.ISRCTN28528813." @default.
- W1967599448 created "2016-06-24" @default.
- W1967599448 creator A5001643187 @default.
- W1967599448 creator A5005113058 @default.
- W1967599448 creator A5013696488 @default.
- W1967599448 creator A5045530644 @default.
- W1967599448 creator A5049999313 @default.
- W1967599448 creator A5058881683 @default.
- W1967599448 creator A5065724991 @default.
- W1967599448 creator A5067360751 @default.
- W1967599448 creator A5068686993 @default.
- W1967599448 creator A5070674274 @default.
- W1967599448 creator A5075958708 @default.
- W1967599448 creator A5075995650 @default.
- W1967599448 creator A5081888215 @default.
- W1967599448 creator A5090039049 @default.
- W1967599448 date "2015-03-04" @default.
- W1967599448 modified "2023-10-16" @default.
- W1967599448 title "Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial" @default.
- W1967599448 cites W1968137793 @default.
- W1967599448 cites W1981535363 @default.
- W1967599448 cites W2063340779 @default.
- W1967599448 cites W2071782320 @default.
- W1967599448 cites W2080567030 @default.
- W1967599448 cites W2084056567 @default.
- W1967599448 cites W2097211328 @default.
- W1967599448 cites W2151319492 @default.
- W1967599448 cites W2171643265 @default.
- W1967599448 cites W4233885503 @default.
- W1967599448 doi "https://doi.org/10.1136/annrheumdis-2014-206404" @default.
- W1967599448 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25739829" @default.
- W1967599448 hasPublicationYear "2015" @default.
- W1967599448 type Work @default.
- W1967599448 sameAs 1967599448 @default.
- W1967599448 citedByCount "188" @default.
- W1967599448 countsByYear W19675994482015 @default.
- W1967599448 countsByYear W19675994482016 @default.
- W1967599448 countsByYear W19675994482017 @default.
- W1967599448 countsByYear W19675994482018 @default.
- W1967599448 countsByYear W19675994482019 @default.
- W1967599448 countsByYear W19675994482020 @default.
- W1967599448 countsByYear W19675994482021 @default.
- W1967599448 countsByYear W19675994482022 @default.
- W1967599448 countsByYear W19675994482023 @default.
- W1967599448 crossrefType "journal-article" @default.
- W1967599448 hasAuthorship W1967599448A5001643187 @default.
- W1967599448 hasAuthorship W1967599448A5005113058 @default.
- W1967599448 hasAuthorship W1967599448A5013696488 @default.
- W1967599448 hasAuthorship W1967599448A5045530644 @default.
- W1967599448 hasAuthorship W1967599448A5049999313 @default.
- W1967599448 hasAuthorship W1967599448A5058881683 @default.
- W1967599448 hasAuthorship W1967599448A5065724991 @default.
- W1967599448 hasAuthorship W1967599448A5067360751 @default.
- W1967599448 hasAuthorship W1967599448A5068686993 @default.
- W1967599448 hasAuthorship W1967599448A5070674274 @default.
- W1967599448 hasAuthorship W1967599448A5075958708 @default.
- W1967599448 hasAuthorship W1967599448A5075995650 @default.
- W1967599448 hasAuthorship W1967599448A5081888215 @default.
- W1967599448 hasAuthorship W1967599448A5090039049 @default.
- W1967599448 hasBestOaLocation W19675994481 @default.
- W1967599448 hasConcept C126322002 @default.
- W1967599448 hasConcept C141071460 @default.
- W1967599448 hasConcept C203014093 @default.
- W1967599448 hasConcept C24040308 @default.
- W1967599448 hasConcept C2776015282 @default.
- W1967599448 hasConcept C2776694085 @default.
- W1967599448 hasConcept C2776755627 @default.
- W1967599448 hasConcept C2776760755 @default.
- W1967599448 hasConcept C2778910314 @default.
- W1967599448 hasConcept C2779134260 @default.
- W1967599448 hasConcept C2779338263 @default.
- W1967599448 hasConcept C2780252810 @default.
- W1967599448 hasConcept C2780653079 @default.
- W1967599448 hasConcept C71924100 @default.
- W1967599448 hasConcept C90924648 @default.
- W1967599448 hasConceptScore W1967599448C126322002 @default.
- W1967599448 hasConceptScore W1967599448C141071460 @default.
- W1967599448 hasConceptScore W1967599448C203014093 @default.
- W1967599448 hasConceptScore W1967599448C24040308 @default.
- W1967599448 hasConceptScore W1967599448C2776015282 @default.
- W1967599448 hasConceptScore W1967599448C2776694085 @default.
- W1967599448 hasConceptScore W1967599448C2776755627 @default.
- W1967599448 hasConceptScore W1967599448C2776760755 @default.
- W1967599448 hasConceptScore W1967599448C2778910314 @default.
- W1967599448 hasConceptScore W1967599448C2779134260 @default.
- W1967599448 hasConceptScore W1967599448C2779338263 @default.
- W1967599448 hasConceptScore W1967599448C2780252810 @default.
- W1967599448 hasConceptScore W1967599448C2780653079 @default.
- W1967599448 hasConceptScore W1967599448C71924100 @default.
- W1967599448 hasConceptScore W1967599448C90924648 @default.
- W1967599448 hasIssue "6" @default.
- W1967599448 hasLocation W19675994481 @default.
- W1967599448 hasLocation W19675994482 @default.
- W1967599448 hasOpenAccess W1967599448 @default.
- W1967599448 hasPrimaryLocation W19675994481 @default.
- W1967599448 hasRelatedWork W2003958157 @default.
- W1967599448 hasRelatedWork W2054305923 @default.
- W1967599448 hasRelatedWork W2077982979 @default.